Reinhard Hohlfeld

THYMIC MYOGENESIS, T‐LYMPHOCYTES AND THE PATHOGENESIS OF MYASTHENIA GRAVIS *

R. Hohlfeld, H. Wekerle, U. Ketelsen, 1981, Annals of the New York Academy of Sciences.

[Revision of McDonald's new diagnostic criteria for multiple sclerosis].

H. Hartung, R. Hohlfeld, H. Wiendl, 2006, Der Nervenarzt.

Multiple Sclerosis Therapy Consensus Group (MSTCG) Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations

R. Gold, Reinhard Hohlfeld, Heinz Wiendl, 2008 .

Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis.

R. Hohlfeld, E. Meinl, F. Weber, 1994, Brain : a journal of neurology.

[Pregnancy and immunomodulatory therapy in multiple sclerosis patients].

R. Hohlfeld, T. Kümpfel, I. Heer, 2006, Der Nervenarzt.

Activation of a myelin basic protein-specific human T cell clone by antigen-presenting cells from rhesus monkeys.

E. Meinl, R. Bontrop, R. de Waal Malefyt, 1995, International immunology.

Paraneoplastic myasthenia gravis: Detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor

H. Thaler, R. Hohlfeld, M. Gautel, 1997, Neurology.